Search research articles
Contact Us
Filters
Showing results (91-100 of 182) with videos related to
Page
of 19
Sort By:
European Urology Oncology
|
August 24, 2024
Cost-utility Analysis of Navigate, a Treatment Decision Aid for Men with Prostate Cancer and Their Partners, in Comparison to Usual Care
Daniel Lindsay, Penelope Schofield, Matthew J Roberts, et al.
BJUI Compass
|
January 5, 2024
Co-designing an online treatment decision aid for men with low-risk prostate cancer: Navigate
Penelope Schofield, Amelia Hyatt, Alan White, et al.
BJU International
|
May 16, 2023
Can <sup>68</sup> Ga-PSMA positron emission tomography and multiparametric MRI guide treatment for biochemical recurrence after radical prostatectomy?
Yash Khanna, Vidyasagar Chinni, Kavitha Gnanasambantham, et al.
The Journal of Pathology
|
July 22, 2014
A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment
Stuart J Ellem, Renea A Taylor, Luc Furic, et al.
The Journal of Urology
|
September 21, 2021
<sup>68</sup>Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography Maximum Standardized Uptake Value as a Predictor of Gleason Pattern 4 and Pathological Upgrading in Intermediate-Risk Prostate Cancer
Alan L Xue, Arveen A Kalapara, Zita E Ballok, et al.
European Urology
|
December 20, 2020
Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial
Rafael E de Feria Cardet, Michael S Hofman, Tatiana Segard, et al.
The Medical Journal of Australia
|
October 2, 2022
Modern paradigms for prostate cancer detection and management
Isabella Sc Williams, Aoife McVey, Sachin Perera, et al.
Pathology
|
September 1, 2012
Utility of RhoC and ZAG protein expression as biomarkers for prediction of PSA failure following radical prostatectomy for high grade prostate cancer
John Mills, Alice Oliver, Justin C Sherwin, et al.
JAMA Network Open
|
January 17, 2025
Personalized Dynamic Prediction Model for Biopsy Timing in Patients With Prostate Cancer During Active Surveillance
Ivo I de Vos, Daan Nieboer, Mark Frydenberg, et al.
Plos One
|
April 20, 2018
Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer
Douglas H Campbell, Maria E Lund, Aline L Nocon, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 182) with videos related to
Sort By:
Page
of 19
European Urology Oncology
|
August 24, 2024
Cost-utility Analysis of Navigate, a Treatment Decision Aid for Men with Prostate Cancer and Their Partners, in Comparison to Usual Care
Daniel Lindsay, Penelope Schofield, Matthew J Roberts, et al.
BJUI Compass
|
January 5, 2024
Co-designing an online treatment decision aid for men with low-risk prostate cancer: Navigate
Penelope Schofield, Amelia Hyatt, Alan White, et al.
BJU International
|
May 16, 2023
Can <sup>68</sup> Ga-PSMA positron emission tomography and multiparametric MRI guide treatment for biochemical recurrence after radical prostatectomy?
Yash Khanna, Vidyasagar Chinni, Kavitha Gnanasambantham, et al.
The Journal of Pathology
|
July 22, 2014
A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment
Stuart J Ellem, Renea A Taylor, Luc Furic, et al.
The Journal of Urology
|
September 21, 2021
<sup>68</sup>Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography Maximum Standardized Uptake Value as a Predictor of Gleason Pattern 4 and Pathological Upgrading in Intermediate-Risk Prostate Cancer
Alan L Xue, Arveen A Kalapara, Zita E Ballok, et al.
European Urology
|
December 20, 2020
Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial
Rafael E de Feria Cardet, Michael S Hofman, Tatiana Segard, et al.
The Medical Journal of Australia
|
October 2, 2022
Modern paradigms for prostate cancer detection and management
Isabella Sc Williams, Aoife McVey, Sachin Perera, et al.
Pathology
|
September 1, 2012
Utility of RhoC and ZAG protein expression as biomarkers for prediction of PSA failure following radical prostatectomy for high grade prostate cancer
John Mills, Alice Oliver, Justin C Sherwin, et al.
JAMA Network Open
|
January 17, 2025
Personalized Dynamic Prediction Model for Biopsy Timing in Patients With Prostate Cancer During Active Surveillance
Ivo I de Vos, Daan Nieboer, Mark Frydenberg, et al.
Plos One
|
April 20, 2018
Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer
Douglas H Campbell, Maria E Lund, Aline L Nocon, et al.
Page
of 19